좌금환이 역류성 식도염 흰쥐에 미치는 영향
Effects of Jwa Kum-Whan on Reflux Esophagitis in Rats
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Objectives: This study was designed to investigate the effects of Jwa Kum-Whan (JKW) on reflux esophagitis in rats. Methods: Forty rats were divided into five groups: a sham group (with no medication and only treated with ventrotoby); a group with reflux esophagitis (RE); a pantoprazole group (treated with 30 mg/kg pantoprazole per day for two weeks); a JKW280 group (treated with 280 mg/kg JKW per day for two weeks); and a JKW560 group (treated with 560 mg/kg JKW per day for 2 weeks). All rats fasted for 24 hrs and then were induced with RE by the oral administration of indomethacin and by a pylorus and forestomach ligation operation. After 8 hrs, the rats were sacrificed. We measured body weight, gastric juice pH, gastric volume, antioxidant activity, and cytokine and made a histologic examination of the esophagus and the stomach. Results: The weights of the rats in each group were not significantly different. The gastric juice pH significantly increased in the JKW560 group and the pantoprazole group compared with the RE group. Gastric volume significantly decreased in the JKW560 group compared with the RE group and the pantoprazole group. SOD activities significantly increased in the JKW280 and JKW560 groups compared with the RE group. Catalase activities significantly increased in the pantoprazole group and the JKW560 group compared with the RE group. TNF-α significantly decreased in the JKW280 and JKW560 groups compared with the RE group. IL-6 significantly decreased in the pantoprazole group and the JKW280 and JKW560 groups compared with the RE group. Histologic examination of the esophagus and the stomach showed significant improvements in the pantoprazole, JKW280, and JKW560 groups compared with the RE group. Conclusion: Based on these results, it is concluded that JKW can prevent reflux esophagitis.
Abstract
Objectives: This study was designed to investigate the effects of Jwa Kum-Whan (JKW) on reflux esophagitis in rats. Methods: Forty rats were divided into five groups: a sham group (with no medication and only treated with ventrotoby); a group with reflux esophagitis (RE); a pantoprazole group (treated with 30 mg/kg pantoprazole per day for two weeks); a JKW280 group (treated with 280 mg/kg JKW per day for two weeks); and a JKW560 group (treated with 560 mg/kg JKW per day for 2 weeks). All rats fasted for 24 hrs and then were induced with RE by the oral administration of indomethacin and by a pylorus and forestomach ligation operation. After 8 hrs, the rats were sacrificed. We measured body weight, gastric juice pH, gastric volume, antioxidant activity, and cytokine and made a histologic examination of the esophagus and the stomach. Results: The weights of the rats in each group were not significantly different. The gastric juice pH significantly increased in the JKW560 group and the pantoprazole group compared with the RE group. Gastric volume significantly decreased in the JKW560 group compared with the RE group and the pantoprazole group. SOD activities significantly increased in the JKW280 and JKW560 groups compared with the RE group. Catalase activities significantly increased in the pantoprazole group and the JKW560 group compared with the RE group. TNF-α significantly decreased in the JKW280 and JKW560 groups compared with the RE group. IL-6 significantly decreased in the pantoprazole group and the JKW280 and JKW560 groups compared with the RE group. Histologic examination of the esophagus and the stomach showed significant improvements in the pantoprazole, JKW280, and JKW560 groups compared with the RE group. Conclusion: Based on these results, it is concluded that JKW can prevent reflux esophagitis.
참고문헌 (46)
- Kahrilas PJ, "GERD pathogenesis, pathophysiology, and clinical manifestations", Cleve Clin J Med, 70(suppl 5), pp.4~19 (2003)
- 서경원, "위식도역류질환의 수술 치료", 대한소화기학회지, 61(3), pp.177~179 (2013), 대한소화기학회
- Vakil N, "The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus", Am J Gastroenterol, 101(8), pp.1900~1920 (2006)
- 이광재, "난치성 위식도역류질환의 원인 및 치료", 대한소화기학회지, 66(2), pp.70~74 (2015), 대한소화기학회
- 유승석, "건강진단검사 수진자에서 식도질환의 유병률", 대한소화기학회지, 50(5), pp.306~312 (2007), 대한소화기학회
- Choi SY, "The Role of Diet and Lifestyle Measures in the Pathogenesis and Treatment of Gastroesophageal Reflux Disease", Korean J Gastroenterol, 37(3), pp.224~225 (2001)
- 정혜경, "위식도역류질환 임상진료지침 개정안 2012", 대한소화기학회지, 60(4), pp.195~218 (2012), 대한소화기학회
- 김지현, "위식도역류질환의 최근 동향", 대한소화기학회지, 64(3), pp.127~132 (2014), 대한소화기학회
- The co-textbook publishing committee of Korean oriental medicine school, "internal medicine of spleen", pp.317~ (2008), Koonja press
- 김희준, "역류성식도염 유발 흰쥐에 대한 二陳湯加味方의 효과", 대한한방내과학회지, 31(1), pp.128~141 (2010), 대한한방내과학회
- 장명웅, "역류성 식도염 유발 생쥐의 半夏瀉心湯 투여 효과에 대한 실험 연구", 대한한방내과학회지, 34(4), pp.362~374 (2013), 대한한방내과학회
- 이영준, "역류성 식도염 랫트에 미치는 金銀花 물 추출물의 치료 효과", 동의생리병리학회지, 24(6), pp.970~975 (2010), 한의병리학회
- 김대준, "吳茱萸 물 추출물이 급성역류성 식도염에 미치는 효과", 대한본초학회지, 27(1), pp.51~58 (2012), 대한본초학회
- Ju JH, "Dangyeeuijip", pp.219~ (1995), Inminwisaeng press
- The co-textbook publishing committee of Korean oriental medicine school, "The herbal medicine", pp.218~219 (2008), Younglimsa
- 최가영, "역류성 식도염의 변증과 처방에 관한 문헌적 고찰 - 중국 논문 중심으로 -", 대한한방내과학회지, 32(1), pp.75~86 (2011), 대한한방내과학회
- Wang J, "Anti-ulcerogenic effect of Zuojin Pill against ethanol-induced acute gastric lesion in animal models", J Ethnopharmacol, 173, pp.459~467 (2015)
- Peng QX, "Extract of Zuojin Pill(左金丸) induces apoptosis of SGC-7901 cells via mitochondria -dependent pathway", Chin J Integr Med, 21(11), pp.837~845 (2015)
- Chen X, "Study on efficacy of liujunzi decoction combined with zuojin pills in treating acute radioactive duodenitis and their mechanism", Zhongguo Zhong Yao Za Zhi, 39(2), pp.278~284 (2014)
- 전수아, "좌금환과 수련환의 항균, 항산화, 미백효과", 석사, 한의학과, pp.2014
- Seong MJ, "Anti-inflammatory effect of Joakeumwhan", pp.2008
- 이영종, "左金丸과 茱連丸이 高脂血症에 미치는 영향", 대한본초학회지, 20(2), pp.91~102 (2005), 대한본초학회
- Choi DH, "Effects of Joakeumwhan(左金丸) Extract on Motility of Intestine and Gastric Secretion", The Journal of Wonkwang Oriental Medicine, 3(1), pp.133~147 (2005)
- 최오철, "배합비율에 따른 左金丸의 간보호 효과", 대한본초학회지, 19(4), pp.67~80 (2004), 대한본초학회
- Fass R, "Refractory GERD:what is it?", Curr gastroenterol Rep, 10(3), pp.252~257 (2008)
- Shukla K, "Effect of Monotherapy and Combination Therapy of Pantoprazole and Aprepitant in Gastric Esophageal Reflux Disease in Albino Rats", Scientific World Journal, 2014, pp.1~7 (2014)
- 최빈혜, "二陳湯加味方의 逆流性 食道炎 抑制效果", 대한한의학회지, 31(5), pp.64~81 (2010), 대한한의학회
- Hwang IK, "Establishment of Functionality Evaluation System for Health Functional Food on Gastrointestinal Tract", pp.2003
- Choi MS, "Antimicrobial Effects of Scutellaria baicalensis, Coptis chinensis, and Phellodendron amurense", pp.2010
- 윤광로, "황련의 항염증효과", 대한본초학회지, 24(3), pp.79~86 (2009), 대한본초학회
- Kim YJ, "Antioxidant Activity of Water-Extract from Coptis chinensis Franch", Korean Journal of Life Science, 10(3), pp.241~246 (2000)
- Lee HJ, "Anti-oxidative activity of evodiae fructus MeOH extract", pp.2007
- Kum SY, "Anti-inflammatory and anti-migration effect of methanol extract of Evodia officinalis DODE in HASMC", pp.2009
- Jeon ES, "Antimicrobial Activity of Streptococcus mutans by Schizandrae fructus and Evodiae fructus extracts", Journal of Dental Hygiene Science, 3(1), pp.39~44 (2003)
- Papadakis MA, "Current Medical Diagnosis & Treatment", pp.590~595 (2015), McGraw-Hill Education
- Locke GR, "Risk factors associated with symptoms of gastroesophageal reflux", Am J Med, 106(6), pp.642~649 (1999)
- DeMeester TR, "Clinical and in vitro analysis of determinants of gastroesophageal competence:a study of the principles of antireflux surgery", Am J Surg, 137(1), pp.39~46 (1979)
- Hunt RH, "Importance of pH control in the management of GERD", Arch Intern Med, 159(7), pp.649~657 (1999)
- Gaynor EB, "Otolaryngologic manifestations of gastroesophageal reflux", Am J Gastroenterol, 86(7), pp.801~808 (1991)
- Wetscher GJ, "Reflux esophagitis in humans is mediated by oxygenderived free radicals", Am J Surg, 170(6), pp.552~557 (1995)
- Rao CV, "Effect of quercetin, flavonoids and alpha-tocopherol, an antioxidant vitamin on experimental reflux oesophagitis in rats", Eur J Pharmacol, 589(1), pp.233~238 (2008)
- Cho SY, "Effects of platycodin D on the reflux esophagitis by modulating antioxidant defense systems", pp.2014
- Rieder F, "Gastroesophageal reflux disease–associated esophagitis induces endogenous cytokine production leading to motor abnormalities", Gastroenterology, 132(1), pp.154~165 (2007)
- Straumann A, "Anti-TNF-α(infliximab) therapy for severe adult eosinophilic esophagitis", J Allergy Clin Immunol, 122(2), pp.425~427 (2008)
- Longo D, "Harrison's Principles of Internal Medicine 18th edition", pp.1906~1908 (2011), McGraw-Hill Professional
- Nagahama K, "Essential role of pepsin in pathogenesis of acid reflux esophagitis in rats", Dig Dis Sci, 51(2), pp.303~309 (2006)
